Search

Participant taking SYMPATHOMIMETICS, ORAL AND INHALED within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking TRICYLIC ANTI-DEPRESSANTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking THYROID AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking THIAZOLIDINEDIONES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking URICOSURICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking VASODILATORS, A MIXED GROUP within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking VASODILATORS WITH DIURETICS, A MIXED GROUP within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking IMMEDIATE-RELEASE VERAPAMIL within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking SLOW-RELEASE VERAPAMIL within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking WEIGHT LOSS DRUGS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Participant taking XANTHINE OXIDASE INHIBITORS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

... are commonly divided into two broad categories: time domain ... intervals and/or less than two hours of combined sleep ... intervals were excluded. - Two sets of HRV analyses ...

... signal file (.EDF) and two versions of the event ... events are represented by two different tags in the ... "Aux_AC" channel instead. - Two subjects (1738, 6476) have ...

... contribute to this time. Two continuous blocks of scorable ... will be displayed in two parts (top/bottom of form), ... returned within one to two weeks of receipt). ### ...

... have transformed the latter two variables with the following ... of the difference between two means of a log-transformed ... less, the ratio of two medians). Not so for ...

... CPAP titration visit, the two month and six month ... following the PSG, including two mood questionnaires (Profile of ... scoring annotations. There are two file sets available, which ...

... these data. As noted, two issues that we feature ... of this, we observed two further indications of technical ... slope distributions for the two central channels). Second, for ...

... Apnea (OSA) are the two most common sleep disorders ... of research attention following two articles in 1999 and ... symptoms shared by the two conditions (e.g. daytime impairments, ...

... are trying to merge two files together? Are these ... was broken up into two pieces (maybe due to ... these EDF files from two separate subjects on separate ...

... also wondering why not two channels of PPG/Pleth were ... oximeter provides PPG at two wavelengths.) What seems to ... provide the PPG at two the wavelengths to avoid ...

... or chronic bronchitis are two types of COPD, yet ... 2/ Asthma: There are two potentially interesting variables for ... wonder which of these two variables might be the ...

Average resting diastolic blood pressure of two measurements collected from the upper arm in a single clinic visit. When more than two measurements were collected, the average was calculated using the second and third measurements. In cases where either of the measurements was missing, the average was calculated discarding the missing value. Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: :dbp: at Visit 5

Average resting systolic blood pressure of two measurements collected from the upper arm in a single clinic visit. When more than two measurements were collected, the average was calculated using the second and third measurements. In cases where either of the measurements was missing, the average was calculated discarding the missing value. Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: :sbp: at Visit 5

When you drink alcohol, do you usually drink during the two hours before bedtime?